Onderneming Conduit Pharmaceuticals Inc.
Aandelen
CDT
US20678X1063
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3 USD | +3,09% | +5,63% | -34,07% |
Vakgebied
Aantal werknemers: 7
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Tapolczay
CEO | Chief Executive Officer | 64 | 22-09-23 |
Adam Sragovicz
DFI | Director of Finance/CFO | 55 | 01-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Freda Lewis-Hall
CHM | Chairman | 69 | 22-09-23 |
Director/Board Member | 50 | 22-09-23 | |
Faith Charles
BRD | Director/Board Member | 62 | 22-09-23 |
Andrew Regan
BRD | Director/Board Member | 59 | 22-09-23 |
David Tapolczay
CEO | Chief Executive Officer | 64 | 22-09-23 |
Chele Farley
BRD | Director/Board Member | 56 | 22-09-23 |
James Bligh
BRD | Director/Board Member | 36 | 22-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 73 829 536 | 9 928 091 ( 13,45 %) | 0 | 13,45 % |
Bedrijfsgegevens
Conduit Pharmaceuticals, Inc.
4995 Murphy Canyon Road Suite 300
92123, San Diego
+
http://www.conduitpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-34,07% | 221 mln. | |
+44,48% | 55,07 mld. | |
+43,57% | 40,22 mld. | |
-0,86% | 41,79 mld. | |
-7,59% | 28,17 mld. | |
+12,30% | 26,28 mld. | |
-21,83% | 18,93 mld. | |
+7,15% | 13,03 mld. | |
+29,40% | 12,26 mld. | |
+25,15% | 12,21 mld. |